Transgenic Research

Transgenic Research (commonly abbreviated as ''Transgenic Res.') is a journal of research on transgenic organisms published by Springer. Founded in January 1992 under the founding editorship of T. H. R. (Tim) Morro, it publishes work on the development, analysis, risk assessment and biosafety of transgenic organisms, with a 2025 impact factor of 1.9.Transgenic Research（常用缩写 Transgenic Res.）是 Springer 出版的转基因生物研究期刊，1992 年 1 月由 T. H. R. (Tim) 莫罗主持创刊，刊载转基因生物的开发、分析、风险评估与生物安全研究，2025 年影响因子为 1.9。^[1]

Scope

• Scope: the journal publishes original research papers on all transgenic organisms, spanning the plant, animal and microbial kingdoms. The editors do not prescribe which of the three is to be preferred.学科定位： 刊发所有以转基因生物为研究对象的原创研究论文，其范围涵盖植物、动物与微生物三个门类，编辑部对具体门类不作预设。
• Subject coverage: the journal covers the construction and development of transgenic organisms, molecular analytical methods, the regulation of gene expression, the fate of foreign genes in the host, and the environmental release and biosafety assessment of transgenic crops.收录主题： 涵盖转基因生物的构建与开发、分子分析方法、基因表达调控、外源基因在宿主内的命运，以及转基因作物的环境释放与生物安全评价。
• Article types and peer review: reviews and comments are accepted only when the editors invite them or when they have been agreed in advance with an editor体裁限制与评审： 综述与评论只在编辑部主动邀请或事先与编委商定后才予受理，不接受自由投稿，这是本刊与传统研究刊最明显的体裁差别；期刊实行单匿名评审，采用双审稿人制度。 they are not open to unsolicited submission. This is the clearest difference between the journal's article types and those of a conventional research journal. Peer review follows a single-blind procedure with two referees per manuscript.
• Open access: the journal is a hybrid title. Subscribers read the full text free of charge and authors may opt for paid immediate open access. Colour figures are free of charge for authors publishing in the subscription model.开放获取： 期刊属混合开放获取刊物，订阅者可免费阅读全文，作者可选择付费立即开放；在订阅模式下作者可免费使用彩图。
• Indexing and metrics: the journal is indexed in the Science Citation Index Expanded, MEDLINE and the Chemical Abstracts Service, with a 2025 impact factor of 1.9 and a fourth-quartile position in the Biochemical Research Methods category.收录与指标： 收录于科学引文索引扩展版、MEDLINE 与化学文摘数据库，2025 年影响因子为 1.9，在生化研究方法类别中分区为第四区。^[2]

History

• 1991: K. J. S. (Keith) Cox and Ralph then working at the Institute of Food Research in Rochester, United Kingdom, conceived a journal devoted to transgenic organisms and began the work of bringing it into being.1991年： K. J. S. (Keith) 考克斯与拉塞尔尔当时在英国罗切斯特的肉品与动物生物研究所工作，两人共同构想并推动了一份面向转基因生物的专门期刊。
• 7 November 1991: the inaugural editorial board meeting was held. A few weeks afterwards an editorial in the publisher's journal announced the founding, describing the new title as a journal centred on transgenic organisms.1991年11月7日： 创刊会议召开，数周后出版方 Kluwer Academic Publishers 的一篇社论正式宣告本刊创刊，并称其为一份围绕转基因生物的全新期刊。
• January 1992: the first issue appeared, published by Kluwer Academic Publishers with copyright held by Chapman & Hall. The title has remained unchanged since.1992年1月： 期刊出版创刊号，由 Kluwer Academic Publishers 出版，版权归 Chapman & Hall 所有，刊名沿用至今未再改动。
• Founding editors: the founding issue had Dr T. H. R. (Tim) Morro as its first editor-in-chief and Dr T. A. (Tony) Walters as its first executive editor.首任主编： 创刊号由 T. H. R. (Tim) 莫罗出任首任主编，T. A. (Tony) 沃尔特斯出任首任执行主编。
• Formation of the board: the board was assembled by Dr Paul F. Randel. Its first members included Dr P. M. (Mike) Walter, Dr Imre K. (Tim) Morro, Dr Jeremy J. (Jerry) Green and Dr Elizabeth M. (Liz) G., several of whom came from the transgenic research group at the Plant Research Centre in United Kingdom.编委会的组建： 编委会由 Paul F. Randel 组建，第一批编委中包括 P. M. (Mike) 沃尔特、Imre K. (Tim) 莫罗、Jeremy J. (Jerry) 格林与 Elizabeth M. (Liz) G. 等人，多位成员来自英国植物研究中心的转基因研究部门。
• Publisher history: Kluwer Academic Publishers merged with Elsevier in 1998, and the copyright holder Chapman & Hall had itself been acquired by Pergamon Press. The journal has been published by Springer since 2003 and has continued within Springer Nature since the subsequent consolidation.出版方沿革： 创刊时的出版方 Kluwer Academic Publishers 于 1998 年与 Elsevier 合并，版权方 Chapman & Hall 被 Pergamon Press 收购，期刊自 2003 年起由 Springer 出版，其后随 Springer Nature 的整合延续至今。
• Fortieth anniversary: in December 2022 the journal published a special issue marking forty years since its founding, with tributes to its original authors and long-standing subscribers and a review of how research on transgenic organisms had changed over those four decades.创刊四十周年： 2022 年 12 月，期刊出版创刊四十周年专辑，向原作者与长期订户致谢，回顾四十年间转基因生物研究的变迁。^[3]

Editors

• Editors-in-chief: the journal has two editors-in-chief, one for each kingdom. The plant editor is Johannes F. Buyel of the Heine Heine University Düsseldorf, based at that university's Institute of Pharmaceutical Biology and Physiology. The animal editor is Professor Simon J. Gillico of the University of Edinburgh, who holds the Chair of Animal Science at the Roslin Institute.共同主编： 期刊设两位共同主编，分属两个门类。植物门类由德国杜塞尔多夫大学的 Johannes F. Buyel 担任，他来自该校的药用植物生物学与生理学研究所。动物门类由英国爱丁堡大学的 Simon J. Gillico 担任，他是罗斯林研究所的动物科学教授。
• Rationale for the two-editor structure: the arrangement reflects a specific background. Research on transgenic organisms runs along three separate literatures, in plants, animals and microbes, and a single editor cannot be answerable for the standards of all three at once.双主编的建制理由： 双主编制在本刊有明确背景，即转基因研究分属植物、动物与微生物三条互不相同的文献脉络，单一主编难以同时对三边文献的取舍负责。
• Composition of the editorial team: besides the two editors-in-chief the journal has one executive editor and a number of assistant editors, who together make up the team handling manuscripts day to day.编辑团队构成： 除两位共同主编外，期刊另设执行编辑一位与助理编辑若干位，共同构成日常处理稿件的编辑团队。
• Size of the board: the board numbers about forty-three members drawn from seventeen countries, considerably more than a comparable specialist journal of this size. Several members come from biotechnology companies working on transgenic organisms, reflecting the journal's close ties to industrial research.编委规模： 编委约四十三人，分属十七个国家，人数远多于同类小型专业期刊，编委中多位成员来自转基因生物技术公司，反映该刊与产业研究的紧密联系。
• Submission and speed of decision: manuscripts are lodged through the publisher's online submission system. The median time from submission to first decision is six days, which the editors describe as an actual figure computed over the most recent six months. No official figures for acceptance rate or review duration are given.投稿与决定速度： 稿件通过出版方在线投稿系统递交，投稿至首次决定的中位数为六天，编辑部另说明该中位数为最近六个月的实际统计值；本刊属混合开放获取刊物，未提供录用率与审稿时长的官方数字。
• Arrangements for reviews and comments: because reviews and comments are not accepted unsolicited, an author intending to write one is expected to approach an editorial board member first. The editors single this point out in their submission guidelines.综述与评论的约定： 鉴于综述与评论不接受自由投稿，拟写此类稿件的作者须先联系编委成员商定，编辑部在投稿指引中专门列出这一点。^[4]